Kevin T Lee Md A Professional Corporation is categorized under Doctors in Temple City, CA and active since 2008.
Kevin T Lee Md A Professional Corporation was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Kevin T Lee at the company’s single location by writing to 5739 Rosemead Boulevard, Temple City, California CA 91780 or by phoning (626) 292-1241. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Kevin T Lee Md A Professional Corporation |
Contact Person: | Kevin T Lee |
Address: | 5739 Rosemead Boulevard, Temple City, California 91780 |
Phone Number: | (626) 292-1241 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Kevin T Lee Md A Professional Corporation was started in 2008 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Kevin T Lee for inquiries that concern Kevin T Lee Md A Professional Corporation by calling the company number (626) 292-1241, as your correspondence is most welcome. Additionally, the physical location of the single location of Kevin T Lee Md A Professional Corporation can be found at the coordinates 34.104181,-118.073815 as well as the street address 5739 Rosemead Boulevard in Temple City, California 91780.
For its online presence, you may visit Kevin T Lee Md A Professional Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.